S4

Supernus Pharmaceuticals IncDUS Supernus Stock Report

Last reporting period 30 Sep, 2024

Updated 12 Nov, 2024

Last price

Market cap $B

1.685

Small

Exchange

XDUS - Boerse Duesseldorf

View Section: Eyestock Rating

Supernus Fair Value

S4

The fair market value of S49.DU stock is 27.44 EUR. Relative to the market price of 34 EUR Supernus is overvalued by 19.3%

Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.

Fair Relative Value

Overvalued 19.3%
27.44 EUR
S49.DU Fair Value
34 EUR
Market price of S49.DU

Supernus Valuation

Current S49.DU share ticker price is 34 EUR.

The fair value level of 27.44 EUR can be considered as an effective entry point for long-term investors to start investing in S49.DU stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.

Price chart is not available

1y
3y
5y
All time
Market price

Current market price

Fair value

Current price is 19% higher its fair value

Min value

Current price is 68% higher its minimum value

Max value

Current price is 61% lower its maximum value

13.11.2024

Market price:

* Eyestock is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on eyestock.io represent a recommendation to buy or sell a security.

S49.DU stock is overvalued

It means the current price may concern as a Risky Entry Point

Supernus Pharmaceuticals Inc Stock Valuation Calculator

How do we value a stock?

As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.

1

Maximum P/E over 5 years

53.73

2

Median P/E over 5 years

26.86

3

Minimum P/E over 5 years

10.52

4

Earning per share (last 12 months)

1.08 USD

Maximum value

1

x

4

=

54.88 EUR

Fair value

2

x

4

=

27.44 EUR

Minimum value

3

x

4

=

10.74 EUR

Supernus Pharmaceuticals Inc price metrics

10.89

Annual return (geometric mean)

41.61

Risk (standard deviation) of returns

β

0.81

Beta (volatility compared to market)

It means that S49.DU stock is less volatile than the broader market

Discover Undervalued Companies


View Section: Profitability